Join
Live feed
·
NEWSReleasevia Quantisnow
Wellgistics Health Inc. logo

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

ByQuantisnow·Wall Street's wire, on your screen.
WGRX· Wellgistics Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WGRX (Wellgistics Health Inc.) and more on Quantisnow.